Navigation Links
Northstar announces that its much-anticipated pet healthcare product will go on sale April 17th

HOLBROOK, N.Y., April 11, 2013 /PRNewswire/ -- Northstar Global Business Services, Inc., Symbol (OTCPink: MDIN), today announced that on April 17th, it will begin to sell HealthEnrich For Pets, a pet healthcare product that is aimed at reversing the aging process and debilitating symptoms of old age in pets utilizing the anti-oxidant, anti-inflammatory, and stem cell replacement properties of the company's proprietary blend of aquatic algae extracts. Currently in talks with at least two major players in the pet industry about distribution and possible licensing, Northstar will begin selling HealthEnrich for Pets on its own website at, and through, but the company expects shipping for nationwide retail distribution to begin shortly thereafter.

The unique properties of the extracts target the painful joints, poor eyesight, low energy, and muscle degeneration that plagues aging dogs and cats, especially pure breeds. "Not only does this product reduce the swelling in joints, and make the animal feel younger and full of energy because of its very potent anti-oxidant and anti-inflammatory properties, but because the active ingredients have the very rare effect of flooding the body with adult stem cells, it allows the pet to heal and re-generate muscle at an astonishing rate," said the company CEO, Nick Chieco . "And I have seen it first hand. My good friend's aging pure breed Pug was practically blind and lame when he started mixing just a few milligrams of the product into the dog's food. Thirty days later I could not recognize the dog, which was running around in circles and chasing squirrels like a puppy. After seeing it with my own eyes, I knew this had to be our next product release."

The company has retooled the product since first announcing its creation. Originally designed to be a daily dog treat, the product is now a liquid that can be easily added to the animal's drinking water. A few drops per day and a generous dose of the all-natural blue-green algae extracts will begin shaving years off of your dog or cat's age. Why a liquid? The company maintains that because the packaging is less expensive, it takes up less room and there is no baking or drying process, the overhead was cut tremendously allowing for a lower retail price and a higher profit margin. The product will retail for $19.99 for a one-month supply and costs the company just under $2.00 per bottle to make. High margins and rapidly increasing revenue are nothing new to Northstar, as you can tell from the company's second quarter disclosure for 2013. The company surprised the world as they showed more than five million dollars in revenue, and is operating in the black, after just three months of sales. The company feels that this product, because of its multi-billion dollar market will put Northstar on the map, and could one day make the company a household name. Until then the company prepares for what it thinks will be overwhelming orders come April 17th. Anyone interested in Northstar or its products can visit, or call Jennifer at 877-571-4387 or email

About Northstar
Northstar Global Business Services is dedicated to producing the best alternative healthcare products. The most popular products in Northstar's arsenal are Snorenz©, a patented spray for snoring relief and Stem-Intense, a unique stem cell replacement therapy supplement. Most of the company's products use a unique spray delivery system, and have received very positive consumer reviews all over the world, selling millions upon millions of units from 1996 to the present.

This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release including such forward-looking statements.

SOURCE Northstar Global Business Services, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
3. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
4. Misonix Announces New Distribution Agreement For Panama
5. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
6. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
7. Boston Scientific Announces CE Mark and European Launch of Emerge™ PTCA Dilatation Catheter
8. Soligenix Announces Further Progress with ThermoVax™ for Long-Term Vaccine ThermoStability
9. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
10. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
11. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... --> adds "Global Repaglinide ... "Investigation Report on China Repaglinide Market, ... forecasts data and information to its ... . --> ...
(Date:11/26/2015)... , Nov. 26, 2015 Research ... addition of the "2016 Future Horizons and ... (TDM) Market: Supplier Shares, Country Segment Forecasts, Competitive ... --> --> ... analysis of the Italian therapeutic drug monitoring market, ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology:
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... a real-time eReferral system for diagnostic imaging in the Waterloo region. Using the ... and Nuclear Medicine tests directly from their electronic medical record (EMR) without the ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug Delivery ... to integrate dose form selection in early phase drug development. The first of ... and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, ...
(Date:11/26/2015)... , ... November 26, 2015 , ... PRMA Plastic Surgery ... 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , “What ... up every day excited to rebuild lives and it’s an honor to have served ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. This newly styled ProTrailer ... classically-influenced trailer titles work with any font, giving users limitless opportunities to stylize ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and distributor of ... server to improve system efficiency and reliability. , The new Q-Suite 6 platform is ... the system avoids locking itself into a specific piece of software for many key ...
Breaking Medicine News(10 mins):